Multiple risk factors of periodontal disease: A study of 9260 Japanese non-smokers

Geriatrics and Gerontology International

Volumn 4, Issue 1, 2004, Pages 37-43

  Hasegawa, Takashi ^a   Watase, Hirotoshi ^a  

^a Public Health Division   (Japan)

Author keywords

Ageing; Diabetes mellitus; Hypertension; Multiple risk factors; Periodontal disease

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; JAPANESE (PEOPLE); LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PERIODONTAL DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; SPECTROPHOTOMETER; URBAN AREA;

EID: 63849178539     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2003.00116.x     Document Type: Article

References (49)

1. The Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial-findings related to a priori hypothesis of the Trial. JAMA 1990; 263: 1795-1801.
2. Manson JE, Tosteson H, Ridker PM et al. The primary prevention of myocardial infarction. N Eng J Med 1992; 326: 1406-1416.
3. DeFronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 1979; 28: 1095-1101.
4. DeFronzo RA, Ferrannini E. Insulin resistance A multifactor syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
5. Torjesen PA, Birkeland KI, Anderssen SA, Hjermann I, Holme I, Urdal P. Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial. Diabetes Care 1997; 20: 26-31.
6. Nelson RG, Shlossman M, Budding LM et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990; 13: 836-840.
7. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991; 62: 123-131.
8. Taylor GW, Burt BA, Becker MP et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996; 67: s1085-s1093.
9. Almas K, Al-Qahtani M, Al-Yami M, Khan N. The relationship between periodontal disease and blood glucose level among type II diabetic patients. J Contmp Dent Pract 2001; 15: 18-25.
10. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontal 2001; 6: 99-112.
11. Karikoski A & Murtomaa H. Periodontal treatment needs in a follow-up study among adults with diabetes in Finland. Acta Odontol Scand 2003; 61: 6-10.
12. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993; 16: 329-334.
13. Ismail AI, Burt BA, Eklund SA. Epidemiologic patterns of smoking and periodontal disease in the United States. J Am Dent Assoc 1983; 106: 617-621.
14. Haber J, Wattle SJ, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993; 64: 16-23.
15. Grossi SG, Zambon JJ, Machtei EE et al. Effect of smoking and smoking cessation on healing after mechanical periodontal therapy. J Am Dent Assoc 1997; 128: 599-607.
16. Arbes SJ Jr, Agustsdottir H, Slade GD. Environmental tobacco smoke and periodontal disease in the United States. Am J Public Health 2001; 91: 253-257.
17. Clarke NG & Hirsch RS. Periodontal risk factors for generalised periodontitis. J Clin Periodontol 1995; 22: 136-145.
18. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am Heart J 1981; 101: 319-328.
19. Burt BA. Periodontitis and aging: Reviewing recent evidence. J Am Dent Assoc 1994; 125: 273-279.
20. Ship JA, Crow HC. Diseases of periodontal tissues in the elderly. Description, epidemiology, etiology and drug therapy. Drugs Aging 1994; 5: 346-357.
21. Willershausen-Zonnchen B, Gleissner C. Periodontal disease in elderly patients. Eur J Med Res 1998; 21: 55-64.
22. Ajwai S, Ainamo A. Periodontal conditions among the old elderly: five-year longitudinal study. Spec Care Dentist 2001; 21: 45-51.
23. Perrson RE, Hollender LG, Powell LV et al. Assessment of periodontal conditions and systemic disease in older subjects. I. Focus on osteoporosis. J Clin Periodontol 2002; 29: 796-802.
24. Gemco RJ, Grossi SG. Is estrogen deficiency a risk factor for periodontal disease? Compend Contin Educ Dent 1998; 22: s23-s29.
25. Mattson JS, Cerutis DR, Parrish LC. Osteoporosis: a review and its dental implications. Compend Contin Educ Dent 2002; 23: 1001-1004.
26. Hasegawa T, Negishi T, Shimizu K, Deguchi M. Lekocyte count as a maker for periodontal index and cigarette smoking. Int Med Jr 2002; 9: 11-14.
27. Hasegawa T, Negishi T, Deguchi M. WBC count, atherosclerosis and coronary risk factors. J Atheroscler Thromb 2002; 9: 219-223.
28. Hasegawa T, Watase H. Heart rate, a marker for coronary risk factors and inflammation. J Atheroscler Thromb 2003; 10: 259-263.
29. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 1972; 18: 499-502.
30. Ainamo J, Barmers D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J 1982; 32: 281-291.
31. Lewis JM, Morgan MV, Wright FA. The validity of the CPITN scoring and presentation method for measuring periodontal conditions. J Clin Periodontol 1994; 21: 1-6.
32. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183.
33. World Health Organization. Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation Presented at the WHO. Geneva: World Health Organization, 1997: Publication WHO/NUT/NCD/98.1.
34. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
35. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497.
36. Mao X, Okamura T, Choudhury SR et al. What unfavorable factors are assocated with low serum total cholesterol in a Japanese population? J Epidemiol 2002; 12: 271-279.
37. Grant MD, Piotrowski ZH, Miles TP. Declining cholesterol and mortality in a sample of older nursing home residents. J Am Geriatr Soc 1996; 44: 31-36.
38. Fagot-Campagna A, Hanson RL, Narayan KM et al. Serum cholesterol and mortality rates in a Native American population with low cholesterol concentrations: a U-shaped association. Circulation 1997; 96: 1408-1415.
39. Boyd LD, Lampi KJ. Importance of nutrition for optimum health of the periodontium. J Contemp Dent Pract 2001; 15: 36-45.
40. Budtz-Jorgensen E, Chung JP, Rapin CH. Nutrition and oral health. Best Pract Res Clin Gastroenterol 2001; 15: 885-896.
41. Krebs R. Adverse reactions with calcium antagonists. Hypertension 1983: 5: II125-II129.
42. Lewis JG. Adverse reactions to calcium antagonists. Drugs 1983; 25: 196-222.
43. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason J. Prevalence of gingival overgrouth induced by calcium channel blockers: a community-based study. J Periodontol 1999; 70: 63-67.
44. Struijker Boudier HA, Le Noble JL, Messing MW et al. The microcirculation and hypertension. J Hypertens Sup 1992; 10: s147-s156.
45. Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T. The role of activated vascular angiotensin II generation in vascular hypertrophy. J Hypertens 1993; 11: 1347-1355.
46. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 1992: 19 (suppl): II62-II67.
47. Boudier HA. Arteriolar and capillary remodeling in hypertension. Drugs 1999; 58: 37-40.
48. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 2003; 5: 155-164.
49. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis. a review of the evidence for the US preventive services task force. Ann Intern Med 2002; 137: 529-541.